TSKU and cholangiocarcinoma: The expression of TSKU was significantly higher in LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), and READ (rectum adenocarcinoma) datasets than in normal tissues (Figure 1B), while the expression of TSKU was lower in cancer than in normal tissues in BRCA (breast invasive carcinoma), CHOL (cholangiocarcinoma), COAD (colon adenocarcinoma), KICH (kidney chromophobe), KIRC (kidney renal clear cell carcinoma), LIHC (liver hepatocellular carcinoma), and STAD (stomach adenocarcinoma) datasets.